<DOC>
	<DOCNO>NCT01566877</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability healthy male female subject intravenous ( IV ) infusion AVI 7288 compare match placebo evaluate pharmacokinetics ( PK ) .</brief_summary>
	<brief_title>A Study Assess Safety , Tolerability Pharmacokinetics AVI-7288 Healthy Adult Volunteers</brief_title>
	<detailed_description>The purpose study evaluate safety tolerability 14 daily intravenous ( IV ) infusion ascend dos AVI 7288 compare match placebo healthy male female subject . To evaluate pharmacokinetics ( PK ) 14 daily dos AVI-7288 healthy male female subject</detailed_description>
	<mesh_term>Hemorrhagic Fevers , Viral</mesh_term>
	<mesh_term>Marburg Virus Disease</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>A subject must meet follow criterion eligible study . 1.Man woman 18 50 year age , inclusive , time screen . 2.Body mass index 18 kg/m2 35 kg/m2 , inclusive , time screen Checkin ( Day 1 ) .3.Good general health ( chronic health condition ) determine Investigator.4.Female subject must nonchildbearing potential must , conjunction sexual partner ( ) , use 2 form medically acceptable barrier contraception ( e.g. , diaphragm spermicidal jelly conjunction male condom ) screen period entire duration study include 28day post last dose followup.5.Male subject must either sterile agree use , entire duration study 90 day post last dose followup , male condom female sexual partner must also use medically acceptable form birth control ( e.g . oral contraceptive ) . 6 . Male subject must agree donate sperm least 90 day last infusion study medication . 7.Able understand requirement study , provide write informed consent ( evidenced signature inform consent document approve Institutional Review Board ( IRB ) , agree abide study restriction . A subject meet follow criterion exclude study . 1.Pregnancy breastfeeding . 2 . A positive urine blood screen drug abuse , include alcohol . 3.Use tobacco nicotinecontaining product ( include limit cigarette , pipe , cigar , chew tobacco , nicotine patch , nicotine lozenge , nicotine gum ) within 6 month prior Checkin ( Day 1 ) . 4.Donated blood within 90 day plasma within 30 day first dose Day 1 . 5.A positive cotinine test indicate recent nicotine use.6.Active substance abuse medical psychiatric condition could jeopardize subject 's safety subject 's ability comply protocol . 7.Use medication apart vitamin , acetaminophen hormonal contraception within 14 day first dose Day 1 . Subjects mild seasonal allergy may use antihistamine discretion Investigator discussion Sponsor Medical Monitor.8.Participation interventional clinical trial within 45 day first dose Day 1 ( i.e. , receive investigational drug ) .9 . Recipient organ transplant ( solid hematopoietic ) . 10.Prolonged QTcF interval &gt; ( 440 m ) males &gt; 460 m female use average triplicate ECGs collect screening , Day 1 , prior dose Day 1 . 11.Other clinically significant electrocardiogram ( ECG ) abnormality , determine Investigator . 12.Any clinically significant abnormal hematology , chemistry , coagulation , urinalysis value , determine Investigator . 13.Glomerular filtration rate ( GFR ) &lt; 90 mL/min , base Modification Diet Renal Disease equation.14.Urinealbumintocreatinine ratio ( UACR ) &gt; 30 mg/g . 15.Positive test human immunodeficiency virus ( HIV1 serology ) know HIV infection . 16.Positive result hepatitis B surface antigen ( HBsAg ) hepatitis C virus ( HCV ) antibody.17.Use alcoholcontaining food beverage within 72 hour prior Checkin Day 1.18.Use caffeinecontaining food beverage within 24 hour prior Checkin Day 1 . 19.Febrile illness significant infection within 48 hour administration first dose study drug Day 1 . Note : Inclusion subject review member Sarepta Therapeutics Clinical Personnel prior enrollment trial . Written approval member Sarepta Therapeutics Clinical Personnel require prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Multiple Ascending Dose ( MAD )</keyword>
	<keyword>Marburg Virus</keyword>
	<keyword>Post Exposure Prophylaxis</keyword>
</DOC>